Royal Bank Of Canada Biogen Inc. Put Options Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$189.07 - $236.8 $170,163 - $213,120
900 New
900 $174,000
Q1 2022

May 16, 2022
SELL
$193.77 - $244.14 $600,687 - $756,834
-3,100 Reduced 62.0%
1,900 $400,000
Q3 2021

Nov 15, 2021
SELL
$282.99 - $369.05 $254,691 - $332,145
-900 Reduced 15.25%
5,000 $1.42 Million
Q2 2021

Aug 16, 2021
BUY
$259.0 - $414.71 $1.53 Million - $2.45 Million
5,900 New
5,900 $2.04 Million

Others Institutions Holding BIIB

# of Institutions
1,038
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email